WT1 and hematologic disorder: Koizumi et al. used mRNA to detect the presence of Wilms’ tumor 1 (WT 1) in several hematological malignancies, including AML, by dPCR, and compared the results with quantitative real-time polymerase chain reaction (RQ-PCR).